Molecular Formula: C
20H
20FNO
3S
Molecular Weight: 373.441103
InChIKey: DTGLZDAWLRGWQN-UHFFFAOYSA-N
Prasugrel is a novel platelet inhibitor developed by Daiichi Sankyo Co. currently marketed in the United States in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). It is approved for use in the U.S., India and Europe.
From: DrugBank